Centene Corp (CNC)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Centene Corp.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 23 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 62.20 $ — 85% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Uses AICentene setzt laut Geschäftsbericht (10-K) 2025 künstliche Intelligenz, Machine Learning und prädiktive Modelle operativ ein, um Kosten zu senken, den Zugang zu wertorientierter Versorgung zu verbessern und die betriebliche Effizienz zu steigern (u. a. Verwaltung, Betrugserkennung, Versorgungssteuerung). KI ist keine eigene Umsatzquelle; die Risikofaktoren nennen KI zudem als Compliance-, Regulierungs- und Sicherheitsrisiko fürs eigene Geschäft. Nach der Vorrangregel überwiegt der belegte operative Einsatz — Einstufung „Nutzt KI".
View the full file — quotes, sources, reviewed filings
„In connection with these initiatives, we have utilized artificial intelligence (AI), Machine Learning (ML), and predictive modeling in ways that lower costs, advance access to value-based care and increase operational efficiencies for each of our employees, members, vendors and provider partners."
Im Zusammenhang mit diesen Initiativen haben wir künstliche Intelligenz (KI), Machine Learning (ML) und prädiktive Modellierung so eingesetzt, dass sie Kosten senken, den Zugang zu wertorientierter Versorgung verbessern und die betriebliche Effizienz für jeden unserer Mitarbeiter, Mitglieder, Lieferanten und Leistungspartner erhöhen.
„We increasingly rely on new and evolving technologies, including those powered by or incorporating artificial intelligence, as part of our internal operations and in the delivery of our products and services."
Wir verlassen uns zunehmend auf neue und sich weiterentwickelnde Technologien, einschließlich solcher, die auf künstlicher Intelligenz beruhen oder diese enthalten, als Teil unseres internen Betriebs und bei der Bereitstellung unserer Produkte und Dienstleistungen.
Rated on July 10, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 13.6% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 19
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4.66 | 3.40 – 5.09 | 194,935 | 124.1% | 20 |
| 12/31/2027 | 5.16 | 4.10 – 6.25 | 192,482 | 10.8% | 21 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.05 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 0.56 | 573.50 | 40,805 | 3.40 | 0.70 | -587 | -741 |
| 2025: Q1 | 2.63 | 21.70 | 46,620 | 15.40 | 2.80 | 1,510 | 1,375 |
| 2025: Q2 | -0.51 | -123.70 | 48,742 | 22.40 | -0.50 | 1,785 | 1,577 |
| 2025: Q3 | -13.50 | -1,091.40 | 49,690 | 18.20 | -13.30 | 1,356 | 1,145 |
| 2025: Q4 | -2.24 | -497.30 | 49,725 | 21.90 | -2.20 | 437 | 224 |
| 2026: Q1 | 3.11 | 18.20 | 49,944 | 7.10 | 3.10 | 3,600 | 3,400 |
| 2026: Q2 | 2.19 | 529.40 | 53,579 | 9.90 | 2.00 | 3,590 | 3,416 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 40,607 | 1,263 | 562 | 1.71 | 1,851 | 5,895 | 20,197 |
| 2017 | 48,382 | 1,199 | 828 | 2.35 | 1,489 | 6,850 | 21,855 |
| 2018 | 60,116 | 1,458 | 900 | 2.26 | 1,234 | 10,917 | 30,901 |
| 2019 | 74,639 | 1,781 | 1,321 | 3.14 | 1,483 | 12,551 | 40,994 |
| 2020 | 111,115 | 3,082 | 1,808 | 3.12 | 5,503 | 25,773 | 68,719 |
| 2021 | 125,982 | 1,784 | 1,347 | 2.28 | 4,205 | 26,795 | 78,375 |
| 2022 | 144,547 | 1,318 | 1,202 | 2.07 | 6,261 | 24,057 | 76,870 |
| 2023 | 153,999 | 2,930 | 2,702 | 4.95 | 8,053 | 25,840 | 84,641 |
| 2024 | 163,071 | 3,175 | 3,305 | 6.31 | 154 | 26,410 | 82,445 |
| 2025 | 194,777 | -7,618 | -6,673 | -13.59 | 5,088 | 19,953 | 77,661 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Centene Corporation ist ein Managed-Care-Unternehmen, das Programme und Dienste für unterversicherte Familien und gewerbliche Organisationen in den USA anbietet. Es ist in vier Segmenten tätig: Medicaid, Medicare, Commercial und Other.
| CEO Insider Trades (12 Mo.) | buying own stock |
|---|---|
| Employees | 61,100 |
| Headquarters | Saint Louis, MO |
| Address | Centene Plaza, 63105 Saint Louis, United States |
| Phone | 314 725 4477 |
| Website | centene.com |
| IPO Date | 13. Dec 2001 |
| ISIN | US15135B1017 |
| Stock Split | 2:1 on 02/07/2019 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Sarah M. London | CEO & Director | 1981 |
| Andrew Lynn Asher | Executive VP & CFO | 1969 |
| Susan R. Smith | Chief Operating Officer | 1976 |
| Christopher Andrew Koster | Executive VP, General Counsel & Secretary | 1965 |
| Tanya M. McNally | Senior VP & Chief People Officer | 1974 |
| Theodore Pienkos | Corporate Controller & Chief Accounting Officer | 1982 |
| Brian Phillip LeClaire M.B.A., Ph.D. | Chief Information Officer | 1960 |
| Jennifer Lynch Gilligan | Senior Vice President of Investor Relations | – |
| Ashlee Knuckey | Chief Risk, Ethics & Compliance Officer | – |
| Cary D. Hobbs | Executive VP & Chief of Staff | 1968 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 28. Jul 2026 | Diaz Paul J | Director | Other | 2,771 | 0.00 | – |
| 17. Jul 2026 | Tyler Lauren M | Director | Other | 3,155 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.